Abstract:Background: Liver metastasis is a common feature of pancreatic tumor and associated with a poor outcome. Invariant natural killer cells (iNKT) are innate-like T cells that are important regulators of innate and adaptive immune responses in cancer and is the largest subset of lymphocytes within liver. However, the role of iNKT cells in pancreatic tumor liver metastasis (PTLM) is still not clear. Hypothesis: activated liver iNKT cells could play a role in PTLM. Method: We established a PTLM mouse model by hemi-spleen murine pancreatic tumor cells (CF1242) injection. We combined single-cell RNA sequencing, flow cytometry analysis, and imaging mass cytometry analysis to landscape the immune profile of tumor microenvironment during PTLM with or without iNKT cell activator α-galactosylceramide (αGC) treatment. Results: αGC treatment significantly blocked PTLM development based on liver weight compared to control group(P<0.001). We sequenced total 6,728 CD45+ infiltrating immune cells in PTLM with/without αGC treatment and identified total 12 immune subpopulations that were present in both samples at different frequencies. Post αGC treatment, activated iNKT cells in liver appeared robust population expansion and enriched in cytotoxic signaling pathway. Alternatively, activated iNKT cells promoted infiltrating CD4 T cells to a Th1 profile shift, and promoted infiltrating CD8 T cells toward an effector/memory phenotype (upregulation of the CD44, T-bet, and IFN-γ; P<0.001), and increased NK cell cytotoxic activity (P<0.001). In addition, we observed that aGC treatment blocked infiltrating CD8 T cell exhaustion by downregulating the immune checkpoint TIGIT, Lag3, and PD-1 (P<0.001). Analysis of tumor-infiltrating myeloid clusters revealed that macrophage skewed to M1 phenotype compared to the control group(P<0.05). Conclusion: αGC treatment can expand and activate liver iNKT cells, which may directly increase tumor cell killing ability, recruit immune cells to tumor sites, and orchestrate the anti-tumor function through boost both innate and adaptive tumor immunity to inhibit PTLM. Our results indicate that iNKT cells may serve as a new immunotherapeutic target for PTLM. (Funded by HFCI and NIH/NIAID) Citation Format: Jie Wang, Qijun Yi, Tingting Liu, Yi Yao, Ian Loveless, Kalpana Subedi, Indra Adrianto, Howard Crawford, Li Zhou, Qing-Sheng Mi. ScRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic tumor liver metastasis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 2108.

Hepatic iNKT cells facilitate colorectal cancer metastasis by inducing a fibrotic niche in the liver

Abstract 1386: CD1d-restricted iNKT cells promote liver metastasis from colon cancer

Tissue resident iNKT17 cells facilitate cancer cell extravasation in liver metastasis via interleukin-22

Targeting Colorectal Cancer Metastasis-Initiating Cells Through Hepatic Inkt Cells

The Hepatic Recruitment of Innate Natural Killer T Cells and Immune-Microenvironment Modulation after Colorectal Cancer Liver Metastasis

Role of Liver-Resident Innate Lymphocytes in Tumor Progress

Abstract 2108: ScRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic tumor liver metastasis

Resting natural killer cells promote the progress of colon cancer liver metastasis by elevating tumor-derived sSCF

Resting natural killer cells promote the progress of colon cancer liver metastasis by elevating tumor-derived stem cell factor

In vivo interaction screening reveals liver-derived constraints to metastasis

Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis

Bimodal role of Kupffer cells during colorectal cancer liver metastasis

Hepatic Regulatory T-cells Promote Colorectal Liver Metastasis in NASH

Data from Th17 Cells Secrete TWEAK to Trigger Epithelial–Mesenchymal Transition and Promote Colorectal Cancer Liver Metastasis

scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver metastasis

KIAA1199 drives immune suppression to promote colorectal cancer liver metastasis by modulating neutrophil infiltration

Invariant Natural Killer T cells control positively and negatively the development of hepatocellular carcinoma

The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity

Immunosuppressive Microenvironment Revealed by Immune Cell Landscape in Pre-metastatic Liver of Colorectal Cancer

Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer

Critical Role of Myeloid-Derived Suppressor Cells in Tumor-Induced Liver Immune Suppression through Inhibition of NKT Cell Function